Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region

被引:2
作者
Woo, Chang Gok [1 ]
Lee, Bora [2 ]
Song, Joon Seon [3 ]
Cho, Kyung-Ja [3 ]
机构
[1] Soonchunhyang Univ, Coll Med, Bucheon Hosp, Dept Pathol, Asan, South Korea
[2] Soonchunhyang Med Ctr, Clin Trial Ctr, Dept Biostat Consulting, Bucheon, Gyeonggi Do, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, 88 Olymp Ro 43gil, Seoul 138736, South Korea
关键词
head and neck neoplasm; Ewing sarcoma; primitive neuroectodermal tumor; PRIMITIVE NEUROECTODERMAL TUMOR; PROGNOSTIC-FACTORS; FUS-ERG; CAVEOLIN-1; BONE; CHEMOTHERAPY; IRRADIATION; METASTASIS; IFOSFAMIDE; MANAGEMENT;
D O I
10.1097/PAI.0000000000000501
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Ewing sarcoma family of tumor (ESFT) is a group of malignant neoplasms that affect children and young adults. Primary ESFT does not commonly arise from the head and neck region. This study aimed to elucidate the clinicopathologic characteristics of ESFT of the head and neck region except for central nervous system primitive neuroectodermal tumors. Among the 207 cases of ESFT of the bone and soft tissue, diagnosed at Asan Medical Center during a 20-year period, 25 (12.1%) involved the head and neck region. Of those, 21 were available for histologic, immunohistochemical, and molecular studies. EWSR1 rearrangement was detected in 19 cases by reverse transcriptase-polymerase chain reaction and/or fluorescence in situ hybridization. Primary sites included the cranial area (6 cases, 31.6%), sinonasal tract (6 cases, 31.6%), paraspinal space (4 cases, 21.0%), and other spaces (3 cases, 15.8%). The 5-year overall survival and disease-free survival rates for all cases were 69.7% and 33.6%, respectively. A large tumor size (>5 cm) correlated significantly with overall survival (P=0.009), but not with disease-free survival (P=0.210). Microscopically, 8 cases (42.1%) showed nested growth pattern. Clear and/or eosinophilic cytoplasm was observed in 68.4% cases. Immunopositivity for CD99, Friend leukaemia integration-1 (FLI-1), CD57, and caveloin-1 were detected in 100%, 88.9%, 83.3%, and 50% cases, respectively. ESFT in the head and neck region had a favorable prognosis and frequent atypical and epithelioid features. An awareness of these histologic and immunophenotypic characteristics will improve the diagnostic accuracy for head and neck round cell malignancies.
引用
收藏
页码:632 / 639
页数:8
相关论文
共 41 条
  • [1] Allam A, 1999, Sarcoma, V3, P11, DOI 10.1080/13577149977811
  • [2] [Anonymous], 2013, WHO CLASSIFICATION T
  • [3] Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript
    Berg, Thomas
    Kalsaas, Ann-Hilde
    Buechner, Jochen
    Busund, Lill-Tove
    [J]. CANCER GENETICS AND CYTOGENETICS, 2009, 194 (01) : 53 - 57
  • [4] Prognostic Factors in Head and Neck Ewing Sarcoma Family of Tumors
    Biswas, Bivas
    Thakar, Alok
    Mohanti, Bidhu K.
    Vishnubhatla, Sreenivas
    Bakhshi, Sameer
    [J]. LARYNGOSCOPE, 2015, 125 (03) : E112 - E117
  • [5] Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors
    Bridge, RS
    Rajaram, V
    Dehner, LP
    Pfeifer, JD
    Perry, A
    [J]. MODERN PATHOLOGY, 2006, 19 (01) : 1 - 8
  • [6] Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH
    Chen, Sonja
    Deniz, Kemal
    Sung, Yun-Shao
    Zhang, Lei
    Dry, Sarah
    Antonescu, Cristina R.
    [J]. GENES CHROMOSOMES & CANCER, 2016, 55 (04) : 340 - 349
  • [7] The Rare Presentation of Extraskeletal Ewing's Sarcoma on the Forehead
    Choi, Sung Hoon
    Kim, Young Joon
    Kim, Hoon
    Kim, Hyun-Jung
    Nam, Sang Hyun
    Choi, Young Woong
    [J]. ARCHIVES OF PLASTIC SURGERY-APS, 2015, 42 (01): : 100 - 102
  • [8] Prognostic factors in Ewing's tumor of bone:: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study group
    Cotterill, SJ
    Ahrens, S
    Paulussen, M
    Jürgens, HF
    Voûte, PA
    Gadner, H
    Craft, AW
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3108 - 3114
  • [9] THE IMMUNOPHENOTYPE OF EWINGS-SARCOMA - AN IMMUNOHISTOCHEMICAL ANALYSIS
    DIERICK, AM
    ROELS, H
    LANGLOIS, M
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (01) : 26 - 32
  • [10] Folpe AL, 2005, AM J SURG PATHOL, V29, P1025